SARS-CoV-2

SERION ELISA agile SARS-CoV-2 IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human antibodies in serum or plasma directed against SARS-CoV-2 and are recommended to support in the diagnosis of COVID-19 and as a complement to direct pathogen detection. In addition SERION ELISA agile SARS-CoV-2 IgG can be used for epidemiological studies.

Highlights

• The utilization of the whole spike protein ensures an early and sensitive detection of SARS-CoV-2 IgG
• Quantitative IgG test allows monitoring of immune response after infection or vaccination 
• Expression of SARS-CoV-2 IgG antibody activity in standardized BAU/ml possible 
• Detection of intrathecally synthesized IgG antibodies for CSF diagnostics 
• Excellent correlation of the IgG test with neutralization assays 
• Sensitive IgA and IgM antibody detection with high specificity ideal for determination of acute infections as complement to direct pathogen detection 
• Quantitative eveluation of IgA antibody activities 
• In house produced antigens guarantee relibale and reproducible results